The hits keep coming: Apotex loses 31 drug approvals after FDA cites plants for 'inadequate' controls

It’s been a troubled few years for Canadian generics maker Apotex after the unsolved murder of founder Barry Sherman and a possible sale in the works. Now, after multiple warnings from the FDA, Apotex faces a future without a big slice of its portfolio.